MAPK3 and Hypercholesterolemia: Our findings of anti-atherogenic properties of ERK1/2 inhibition have been confirmed by a recent report, which demonstrates protection against hypercholesterolemia and atherosclerosis by deficiency of orphan G protein-coupled receptor 146 (GPR146) expression is tightly linked to reduced ERK1/2 activity 30.